These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


335 related items for PubMed ID: 6092989

  • 1. Recovery of the hypothalamo-pituitary-adrenocortical axis in the rat after long-term dexamethasone treatment.
    Nicholson S, Campbell E, Torrellas A, Beckford U, Altaher R, Sandford R, Scraggs R, Gillham B, Jones M.
    Neuroendocrinology; 1984 Oct; 39(4):343-9. PubMed ID: 6092989
    [Abstract] [Full Text] [Related]

  • 2. Recovery of the components of the hypothalamo-pituitary-adrenocortical axis in the rat after chronic treatment with prednisolone.
    Nicholson SA, Campbell EA, Gillham B, Jones MT.
    J Endocrinol; 1987 May; 113(2):239-47. PubMed ID: 3035051
    [Abstract] [Full Text] [Related]

  • 3. Effects of chronic maternal dexamethasone treatment on the hormones of the hypothalamo-pituitary-adrenal axis in the rat fetus.
    Dupouy JP, Chatelain A, Boudouresque F, Conte-Devolx B, Oliver C.
    Biol Neonate; 1987 May; 52(4):216-22. PubMed ID: 2823915
    [Abstract] [Full Text] [Related]

  • 4. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG, Patchev V, Vergalla J, Chrousos G, Jones EA.
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [Abstract] [Full Text] [Related]

  • 5. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J, Grino M, Bernet F, Dutriez-Casteloot I, Montel V, Dupouy JP.
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [Abstract] [Full Text] [Related]

  • 6. Corticotropin secretagogues facilitate recovery of the hypothalamus-pituitary-adrenal axis suppressed by prolonged treatment with dexamethasone.
    Huang TS.
    Metabolism; 1994 May; 43(5):544-8. PubMed ID: 8177041
    [Abstract] [Full Text] [Related]

  • 7. The site of inhibitory action of a natural (corticosterone) and synthetic steroid (dexamethasone) in the hypothalamic-pituitary-adrenal axis.
    Sakakura M, Yoshioka M, Kobayashi M, Takebe K.
    Neuroendocrinology; 1981 Mar; 32(3):174-8. PubMed ID: 6261179
    [Abstract] [Full Text] [Related]

  • 8. Diurnal variations in responsiveness of the hypothalamo-pituitary-adrenocortical axis of the rat.
    Nicholson S, Lin JH, Mahmoud S, Campbell E, Gillham B, Jones M.
    Neuroendocrinology; 1985 Mar; 40(3):217-24. PubMed ID: 2986024
    [Abstract] [Full Text] [Related]

  • 9. Effects of treatment with adrenocorticotrophin on the hypothalamo-pituitary-adrenal system.
    Stark E, Kárteszi M, Rappay G, Makara GB.
    J Endocrinol; 1981 Jan; 88(1):131-9. PubMed ID: 6257818
    [Abstract] [Full Text] [Related]

  • 10. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
    Buckingham JC, Cooper TA.
    Neuroendocrinology; 1986 Jan; 42(5):421-6. PubMed ID: 3010154
    [Abstract] [Full Text] [Related]

  • 11. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD, Oitzl MS, Workel JO, de Kloet ER.
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [Abstract] [Full Text] [Related]

  • 12. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
    Calogero AE, Kamilaris TC, Johnson EO, Tartaglia ME, Chrousos G.
    Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
    [Abstract] [Full Text] [Related]

  • 13. [Studies of the hypothalamo-hypophyseal corticoliberin system. VII. Effect of ether stress and dexamethasone on the hypothalamo-hypophyseal-adrenal axis].
    Miśkowiak B, Partyka M.
    Endokrynol Pol; 1992 Oct; 43(2):171-81. PubMed ID: 1345539
    [Abstract] [Full Text] [Related]

  • 14. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
    Huang TS.
    J Endocrinol Invest; 1997 Oct; 20(7):393-6. PubMed ID: 9309537
    [Abstract] [Full Text] [Related]

  • 15. Blunted pituitary-adrenocortical stress response in adult rats following neonatal dexamethasone treatment.
    Felszeghy K, Bagdy G, Nyakas C.
    J Neuroendocrinol; 2000 Oct; 12(10):1014-21. PubMed ID: 11012843
    [Abstract] [Full Text] [Related]

  • 16. Ontogeny of the stress response in the rat: role of the pituitary and the hypothalamus.
    Walker CD, Perrin M, Vale W, Rivier C.
    Endocrinology; 1986 Apr; 118(4):1445-51. PubMed ID: 3004915
    [Abstract] [Full Text] [Related]

  • 17. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
    Dallman MF, Makara GB, Roberts JL, Levin N, Blum M.
    Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
    [Abstract] [Full Text] [Related]

  • 18. Dopamine-beta-hydroxylase activity is necessary for hypothalamo-pituitary-adrenal (HPA) responses to ether, and stress-induced facilitation of subsequent HPA responses to acute ether emerges as HPA responses are inhibited by increasing corticosterone (B).
    Murakami K, Akana SF, Dallman MF.
    J Neuroendocrinol; 1997 Aug; 9(8):601-8. PubMed ID: 9283048
    [Abstract] [Full Text] [Related]

  • 19. Immunoneutralization of lipocortin 1 reverses the acute inhibitory effects of dexamethasone on the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat in vitro and in vivo.
    Taylor AD, Loxley HD, Flower RJ, Buckingham JC.
    Neuroendocrinology; 1995 Jul; 62(1):19-31. PubMed ID: 7566434
    [Abstract] [Full Text] [Related]

  • 20. Corticosterone-induced changes in hypothalamic corticotropin-releasing factor (CRF) content after stress.
    Sato T, Sato M, Shinsako J, Dallman MF.
    Endocrinology; 1975 Aug; 97(2):265-74. PubMed ID: 169120
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.